Genovac AG, headquartered in Germany, is a leading player in the biotechnology industry, specialising in the development of innovative antibody discovery and engineering solutions. Founded in 2000, the company has established itself as a trusted partner for pharmaceutical and biotechnology firms, offering a range of services that include monoclonal antibody production and custom assay development. With a strong presence in Europe and North America, Genovac AG is renowned for its unique proprietary technologies that streamline the antibody discovery process, significantly reducing time-to-market for therapeutic candidates. The company has achieved notable milestones, including collaborations with major pharmaceutical companies, which underscore its market position as a key contributor to advancements in biopharmaceutical research. Genovac AG continues to drive innovation, making it a pivotal entity in the evolving landscape of biotechnology.
We don't have data for Genovac AG, but we can show you information about their parent organization instead.
View parent company